Vtv Therapeutics Inc. · NASDAQ:VTVT
Srinivas Akkaraju reported a 9.90% stake in Vtv Therapeutics Inc. (Schedule 13D/A)
Event Dec 8, 2025 · Filed Dec 9, 2025
Srinivas Akkaraju reported a 9.90% stake in Vtv Therapeutics Inc., 403,942 shares, with active intent on Dec 8, 2025. Filed Dec 9, 2025 (Schedule 13D/A).
- Stake
- 9.90%
- Shares
- 403,942
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 6.20% | 246,484 |
| Samsara BioCapital GP, LLC | 6.20% | 246,484 |
| Samsara Opportunity Fund, L.P. | 3.80% | 152,893 |
| Samsara Opportunity Fund GP, LLC | 3.80% | 152,893 |
| Srinivas Akkaraju | 9.90% | 403,942 |
Source
Related
- Vtv Therapeutics Inc.
- Akkaraju Srinivas
- Vtv Therapeutics Inc. shareholders
- Schedule 13D/A · Akkaraju Srinivas · Sep 25, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 29, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 16, 2026
- Schedule 13G · Millennium Management LLC · Mar 27, 2026
- Schedule 13G/A · Invus Public Equities, L.P. · Nov 12, 2025